A major discovery in cancer investigation is arising with the use of VHH fragments to reactivate dysfunctional p53. This crucial cancer suppressor protein is frequently disabled in several forms of tumors, resulting https://gogogobookmarks.com/story21981893/mini-antibodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-cancer-management